<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17905" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Asplenia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ashorobi</surname>
            <given-names>Damilola</given-names>
          </name>
          <aff>Nassau University Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Fernandez</surname>
            <given-names>Roberto</given-names>
          </name>
          <aff>Nassau University Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Damilola Ashorobi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Roberto Fernandez declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>10</day>
          <month>9</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17905.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Asplenia means the absence of a spleen. Asplenia can occur in a variety of clinical settings, and it can refer to an anatomic absence of the spleen or functional asplenia secondary to a variety of disease states. The spleen is one of the primary extramedullary lymphoid organs. It is located in the left upper quadrant of the abdomen. Normally, the spleen is not palpable on physical exam and measures on average 10.65 by 5.16 cm. Normal spleen size can vary by sex and race. For example, men, on average, have larger spleens than females, and whites, on average, tend to have larger spleens compared to African American individuals. This activity reviews the pathophysiology and diagnosis of infections in patients with asplenia and highlights the role of the interprofessional team in the management of these patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the causes of asplenia.</p></list-item><list-item><p>Recall the type of infections that can occur in patients with asplenia.</p></list-item><list-item><p>List the treatment and management options available for infections in patients with asplenia.</p></list-item><list-item><p>Discuss interprofessional team strategies for improving care and outcomes in patients with asplenia.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17905&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17905">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17905.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Asplenia means the absence of a spleen. Asplenia can occur in various clinical settings, and it can refer to an anatomic absence of the spleen or functional asplenia secondary to a variety of disease states. The spleen is one of the primary extramedullary lymphoid organs. It is located in the left upper quadrant of the abdomen. Normally, the spleen is not palpable on physical exam and measures on average 10.65 by 5.16 cm. Normal spleen size can vary by sex and race. For example, men have larger spleens than women, and White individuals, on average, tend to have larger spleens compared to African American individuals.<xref ref-type="bibr" rid="article-17905.r1">[1]</xref> When palpable or notably enlarged on imaging, the clinician must consider a variety of underlying disease states (whether acquired or inherited) contributing to the enlargement.</p>
        <p>Functionally, the spleen&#x02019;s primary physiologic role is the filtration and processing of senescent blood cells (predominantly red blood cells or RBCs) and immunologically helps protect against encapsulated microorganisms and respond to infectious pathogens. It contains hematopoietic and lymphopoietic elements, providing a basis for extramedullary hematopoiesis when necessary.<xref ref-type="bibr" rid="article-17905.r2">[2]</xref> The spleen has 2 functionally and histologically distinct tissues where these processes take place: the white pulp and the red pulp. The white pulp has a large mass of lymphoid tissue that produces antibodies against recognized antigens, whereas the red pulp has a tight network of sinusoids called the cord of Billroth, which helps in blood filtration.<xref ref-type="bibr" rid="article-17905.r3">[3]</xref> As the body's largest filter of blood, it helps to remove old RBCs from circulation,&#x000a0;aiding in the removal of blood-borne microorganisms.<xref ref-type="bibr" rid="article-17905.r4">[4]</xref> Beyond the spleen, the lymphatic system of the body consists of a complex myriad of lymphatic vessels, lymph nodes, and other specific extramedullary lymphoid organs, including the thymus, tonsils, and appendix, which collectively play a very important role in immune defenses.</p>
        <p>Asplenia can be caused by damage to the white pulp, the red pulp, or both. The spleen is a direct and indirect site of potential toxicity that can arise from underlying disease processes or infection.<xref ref-type="bibr" rid="article-17905.r2">[2]</xref> One must understand and appreciate the various etiologies and potential complications of asplenia, such as being a great risk factor for encapsulated microorganisms. Bacterial infections with <italic toggle="yes">Neisseria meningitides</italic> or <italic toggle="yes">Streptococcal pneumoniae</italic>, among many others, can become life-threatening if untreated in patients with anatomic or functional asplenia.<xref ref-type="bibr" rid="article-17905.r5">[5]</xref>&#x000a0;Patients without a spleen have a 200-fold greater risk of death from septicemia compared to those with an adequate functioning spleen. There are many case reports in the medical literature reporting of asplenic patients, unfortunately, succumbing to infectious diseases leading to death. One notable example reported by Heubner ML et al (2015) described the rare case of a patient who had required splenectomy due to refractory immune thrombocytopenia (ITP).<xref ref-type="bibr" rid="article-17905.r6">[6]</xref> He subsequently developed a pneumococcal meningitis infection and died despite best supportive efforts. The rate of invasive bacterial infection and mortality in asplenic patients is significantly higher compared to normal controls&#x02014;69% in meningitis, 64% in septicemia, and 7% in <italic toggle="yes">Purpura fulminans</italic>.<xref ref-type="bibr" rid="article-17905.r5">[5]</xref></p>
      </sec>
      <sec id="article-17905.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Asplenia can be acquired, functionally reduced despite its anatomic presence, or in those who congenitally lack a spleen at birth. Most commonly, acquired asplenia is due to surgical removal or trauma. According to a survey by the National Hospital Discharge Survey in the United States done in 2005, approximately 22,000 splenectomies were performed.<xref ref-type="bibr" rid="article-17905.r7">[7]</xref> The most common indication for splenectomy was due to preceding trauma. According to a retrospective study that reviewed the historic clinical indications for splenectomy, traumatic injury accounted for more than 41.5%; hematologic malignancy accounted for 15.4%, and cytopenias accounted for 15.4% of all splenectomies performed.<xref ref-type="bibr" rid="article-17905.r8">[8]</xref></p>
        <p>A variety of benign and malignant hematologic disorders can result in the potential need for splenectomy. Some examples include hereditary spherocytosis, sickle cell disease, thalassemia major or intermedia, refractory immune thrombocytopenia (ITP), myeloproliferative disorders (eg, severe or symptomatic splenomegaly in myelofibrosis), certain types of autoimmune hemolytic anemias, lymphoproliferative disorders, and rarely in thrombotic thrombocytopenic purpura (TTP).<xref ref-type="bibr" rid="article-17905.r3">[3]</xref>&#x000a0;Congenital asplenia may be isolated or as a clinical sequela of broader (albeit rare) clinical syndromes such as Ivemark syndrome. This syndrome is classified under heterotaxy syndrome. It is associated with asplenia or hypoplasia of the spleen, malformation of the heart, and abnormal arrangements of organs of the chest and abdomen.<xref ref-type="bibr" rid="article-17905.r9">[9]</xref></p>
        <p>In addition to the more common causes of asplenia, many other etiologies have been described in the literature affecting various body systems as listed below.</p>
        <list list-type="bullet">
          <list-item>
            <p>Gastrointestinal (GI) disorders such as Celiac disease, Whipple disease, and inflammatory bowel diseases (IBD) can be&#x000a0;associated with hypofunction of the spleen.<xref ref-type="bibr" rid="article-17905.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p>Infectious disease states and acquired immune deficiency syndromes, including HIV.<xref ref-type="bibr" rid="article-17905.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p>Hepatic disorders such as alcoholic liver disease, cirrhosis, portal hypertension, and hepatorenal syndrome.<xref ref-type="bibr" rid="article-17905.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p>Rheumatologic conditions such as systemic lupus erythematosus (SLE) have been associated with reduced spleen function.<xref ref-type="bibr" rid="article-17905.r3">[3]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17905.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The epidemiology of asplenia differs depending on its etiology. Nearly 100% of sickle cell anemia patients (ie, those with hemoglobin SS disease) will develop asplenia, and they are prone to overwhelming post-splenectomy infection.<xref ref-type="bibr" rid="article-17905.r10">[10]</xref> Many other patients with similar hemoglobinopathies are at risk of splenomegaly and a possible need for splenectomy or may develop functional asplenia with the course of their disease (eg, hemoglobin SC disease). Other diseases associated with reduced function of the spleen include celiac disease, with an estimated prevalence of 33% to 76%, Whipple&#x000a0;disease (47%), and alcoholic liver disease (37% to 100%).<xref ref-type="bibr" rid="article-17905.r10">[10]</xref>&#x000a0;Remark syndrome is seen in 1 in 10,000 to 40,000 cases.<xref ref-type="bibr" rid="article-17905.r5">[5]</xref></p>
      </sec>
      <sec id="article-17905.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of asplenia also varies depending on the underlying etiology and comorbid conditions. In many benign hematologic disorders, for example, functional asplenia is caused by persistent and recurrent hyper-sequestration of red blood cells (RBCs), leading to RBC entrapment. This entrapment leads to splenic enlargement and then later atrophy. Profound atrophy of the spleen is also known as autosplenectomy. Autosplenectomy is usually seen in sickle cell anemia patients, especially those with HgbSS disease.<xref ref-type="bibr" rid="article-17905.r10">[10]</xref> In hematologic malignancies, by contrast, asplenia may result from direct infiltration of the malignant cells into the parenchyma of the spleen.&#x000a0;</p>
        <p>Many GI disorders can lead to functional&#x000a0;asplenia. For example, in cases of hepatic dysfunction or failure, asplenia can develop due to the disruption of the normal hepatic circulation, such as in portal hypertension. Alcohol consumption has been known to cause a direct toxic effect on splenic tissue.<xref ref-type="bibr" rid="article-17905.r10">[10]</xref> In other disorders like Celiac disease, asplenia is caused by excessive loss of lymphocytes through inflamed enteric mucosa, leading to reticuloendothelial atrophy.<xref ref-type="bibr" rid="article-17905.r10">[10]</xref></p>
      </sec>
      <sec id="article-17905.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histologically, atrophy of the spleen is evident by degeneration of white pulp (ie, decreased periarteriolar lymphatic sheaths, or PALS, decreased follicles, germinal centers, and marginal zones). Decreased amounts of hematopoietic components characterize red pulp atrophy. Cytologically, the presence of Howell-Jolly bodies and pitted red blood cells visible upon review of a peripheral blood smear may suggest&#x000a0;asplenia or reduced function of the spleen. Other non-specific cytologic findings include absolute monocytosis, lymphocytosis,&#x000a0;and/or thrombocytosis.<xref ref-type="bibr" rid="article-17905.r11">[11]</xref></p>
      </sec>
      <sec id="article-17905.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with asplenia can be asymptomatic, while some can present with malaise, fatigue, fever, or encephalopathy. On physical examination, a normal spleen is not palpable. &#x000a0;When enlarged, it can typically be palpated below the costophrenic border on deep inspiration. In patients with various degrees of functional asplenia (autosplenectomy), the spleen will usually not be palpable due to chronic atrophy.&#x000a0;Patients may also present with signs or symptoms indicative of underlying infection. Severe infection due to&#x000a0;<italic toggle="yes">Streptococcus pneumoniae</italic>, <italic toggle="yes">Haemophilus influenzae</italic>, and <italic toggle="yes">Neisseria meningitides</italic> are the most common bacterial infections recognized in these patients. As such, it is important to assess for nuchal rigidity in these patients if they present with fever. In particular, pneumococcal meningitis can be up to four times more fatal in asplenic patients compared to other forms of bacterial meningitis and over 6 times more likely to result in poor health outcomes.<xref ref-type="bibr" rid="article-17905.r6">[6]</xref></p>
      </sec>
      <sec id="article-17905.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>As noted, analysis of the peripheral blood smear may demonstrate the presence of Howell-Jolly bodies, providing the clinician with a clue of underlying splenic dysfunction (e.g., congenital or functional asplenia). To confirm physical exam findings and establish the anatomic presence (or absence) and measurement of the spleen, various imaging modalities can be utilized, including abdominal&#x000a0;ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), or spleen scintigraphy.<xref ref-type="bibr" rid="article-17905.r5">[5]</xref>&#x000a0;Using ultrasonography, CT, or MRI of the abdomen may also help in better characterization of possible congenital or vascular abnormalities. Spleen scintigraphy is a specialized imaging modality using a 99-Tc labeled radio colloid that is specific for splenic tissue; a lack of uptake signifies asplenia.</p>
      </sec>
      <sec id="article-17905.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>As noted, patients with asplenia are at a significantly increased risk of severe bacterial infection, especially from encapsulated microorganisms. As a result, efforts have been made over the last decade to improve the prevention, early detection, and management of infections encountered in asplenic patients. The most common bacterial pathogen leading to infection in patients with asplenia is <italic toggle="yes">Streptococcus pneumoniae</italic>. According to one study by Waghorn et al, up to 87% of asplenic patients were found to have been infected with Strep. pneumoniae.<xref ref-type="bibr" rid="article-17905.r12">[12]</xref>&#x000a0;To avoid morbidity, regardless of the cause of their asplenia, all patients should be counseled to receive vaccinations against these encapsulated bacteria. Vaccinations are recommended before splenectomy and after the surgical removal. Individuals with functional asplenia (or autosplenectomy) are also advised to continue aggressive vaccination schedules. Before planned surgery for splenectomy, it is recommended that patients receive the pneumococcal conjugate vaccine (PCV-13) 8 weeks in advance, as well as the pneumococcal polysaccharide vaccine (PPSV-23), <italic toggle="yes">Haemophilus influenzae</italic> type B vaccine (Hib), and the quadrivalent meningococcal conjugate vaccine 14 days before surgery.<xref ref-type="bibr" rid="article-17905.r6">[6]</xref>&#x000a0;</p>
        <p>Vaccination must continue in the postoperative period, and 5 years after the surgery, it is recommended that patients receive the PPSV-23 and then again at age 65. The meningococcal conjugate vaccine should be repeated every 5 years.<xref ref-type="bibr" rid="article-17905.r13">[13]</xref> For those with acquired immunodeficiency, it may be advisable to check for titers to determine immune status. Apart from all these vaccines, patients should be encouraged to receive annual vaccination against the common strains of influenza. It has been recommended that prophylactic penicillin be considered in children with asplenia (eg, patients with sickle cell disease) until the age of 5,<xref ref-type="bibr" rid="article-17905.r14">[14]</xref> although this prophylaxis is not recommended in adults. Asplenic adults, however, should have antibiotics readily available via their healthcare provider if they develop&#x000a0;signs of infection, as any delay in antibiotic access may be detrimental.<xref ref-type="bibr" rid="article-17905.r6">[6]</xref></p>
        <p>Overwhelming post-splenectomy infection is common, especially in children younger than 16 years old, due to their immune immaturity.<xref ref-type="bibr" rid="article-17905.r10">[10]</xref> Patients with asplenia who present with signs of infection should be immediately started on broad-spectrum antibiotics until further testing can isolate the causative microorganism. According to the Surviving Sepsis Campaign guidelines, patients suspected of sepsis should be started on antibiotics within 1 hour to avoid poor outcomes.<xref ref-type="bibr" rid="article-17905.r14">[14]</xref> Aggressive intravenous (IV) hydration should also be promptly initiated as per standard sepsis guidelines and as part of supportive care. Since asplenic patients are prone to developing septic shock, they may also require vasopressors to maintain their blood pressure. In certain circumstances, mechanical ventilation may be necessary if patients develop respiratory failure.</p>
      </sec>
      <sec id="article-17905.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of asplenia includes hyposplenia. Hyposplenia shares many of the clinical features as asplenia and may precede further functional decline or autosplenectomy. Unlike asplenia, hyposplenia may be reversible if the underlying condition is treated. For instance, in patients with Celiac disease who develop hyposplenia, the spleen can return to normal function if the celiac disease is better controlled.</p>
      </sec>
      <sec id="article-17905.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of asplenia is poor if left unrecognized, as patients will be at higher risk of infection without proper vaccination. Antibiotic prophylaxis and vaccinations are the recommended management modalities in many patients who are asplenic and those with acquired immunodeficiency and asplenia.<xref ref-type="bibr" rid="article-17905.r10">[10]</xref> As noted, patients who do not receive immunizations are at high risk of severe bacterial infection, sepsis, septic shock, and death. One case report by Huebner and colleagues provides evidence of the poor&#x000a0;prognosis in asplenic patients who succumb to infection despite receiving standard medical care. This case described a 45-year-old man with a history of splenectomy during childhood who presented with high fevers. He was found to have pneumococcal meningitis and was appropriately started on antibiotics and fluid resuscitation, though unfortunately, his clinical status deteriorated quickly, and he was pronounced dead from sepsis.<xref ref-type="bibr" rid="article-17905.r6">[6]</xref>&#x000a0;Many such illustrative cases and case series are reported in the medical literature.</p>
      </sec>
      <sec id="article-17905.s12" sec-type="Complications">
        <title>Complications</title>
        <p>The most common medical complication in asplenic patients is an overwhelming post-splenectomy infection (OPSI). As noted, asplenic patients are at higher risk of infection with encapsulated microorganisms (eg, streptococcal pneumonia). According to Kirkineska and colleagues, OPSI results in&#x000a0;massive bacteremia caused by encapsulated microorganisms. The primary source of infection is not commonly identified; there is a short prodromal phase and septic shock occasionally associated with disseminated intravascular coagulopathy (DIC) can occur. Up to 60% to 70% mortality rate has been observed in patients with OPSI if not appropriately managed.<xref ref-type="bibr" rid="article-17905.r10">[10]</xref></p>
        <p>In a normal functioning spleen, the red pulp filters blood and removes old red blood cells; it causes phagocytosis of infected erythrocytes, which helps to form a defense against intraerythrocytic parasites.<xref ref-type="bibr" rid="article-17905.r15">[15]</xref>&#x000a0;Parasitic infections such as babesiosis and malaria are common in patients with asplenia due to loss of phagocytosis. The white pulp of the spleen has both T-cell and B-cell compartments, which help with adaptive immunity and antibody production. The spleen provides the largest B cells, which help in the humoral immune response.<xref ref-type="bibr" rid="article-17905.r15">[15]</xref> The lack of memory B cells in the asplenic individual causes severe illness compared to the general population. Because the spleen functions as a reservoir for non-circulation and undifferentiated monocytes, splenectomy causes a lack of this reserve. According to Swirski et al, these undifferentiated monocytes stored in clusters in the red pulp, respond to myocardial injury and help in wound healing.<xref ref-type="bibr" rid="article-17905.r16">[16]</xref></p>
        <p>Apart from its role in immunity, the spleen also has a role in vascular and thrombotic complications. Vascular complications were also observed, mostly in patients with hematologic diseases like beta-thalassemia. In a survey done by Taher et al, they found that in patients with asplenia due to beta-thalassemia, the prevalence of thrombotic events was 1.65%.<xref ref-type="bibr" rid="article-17905.r17">[17]</xref>&#x000a0;There have also been increased incidences of stroke, myocardial infarction, and CAD in these patients.<xref ref-type="bibr" rid="article-17905.r18">[18]</xref>&#x000a0;These vascular complications could be due to chronic inflammation and dysfunction of the endothelium. The destruction of the endothelial lining could lead to platelet activation and thrombosis.<xref ref-type="bibr" rid="article-17905.r15">[15]</xref></p>
        <p>Due to the risk of thrombosis in patients with asplenia, another complication reported is pulmonary hypertension. According to Hoeper et al., the incidence of pulmonary hypertension in patients with asplenia is 8% to 11.5%, and numbers are even higher in patients with hemoglobinopathies.<xref ref-type="bibr" rid="article-17905.r15">[15]</xref> In patients with sickle cell or beta-thalassemia, the incidence could be as high as 30%.<xref ref-type="bibr" rid="article-17905.r19">[19]</xref>&#x000a0;Patients also can develop adrenal hemorrhage, also known as Waterhouse-Friedrichsen syndrome, and purpura fulminans.<xref ref-type="bibr" rid="article-17905.r20">[20]</xref> These two conditions require a high index of suspicion by the treating clinician. Early recognition and management are critical to avoid morbidity and mortality.</p>
      </sec>
      <sec id="article-17905.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>The primary goal in all&#x000a0;asplenic patients is to provide adequate preventive medicine. Patients with asplenia need to understand the complications involved, especially the risk of serious infection, which can result in premature death. Vaccinations and prophylactic antibiotics (in certain clinical circumstances) need to be emphasized. Specifically, patients with asplenia should be up to date on their pneumococcus, meningitis, <italic toggle="yes">Haemophilus,</italic> and influenza vaccinations. Recommended prophylactic antibiotics typically include amoxicillin and penicillin.<xref ref-type="bibr" rid="article-17905.r6">[6]</xref>&#x000a0;In certain contexts (eg, young children with asplenia or immunocompromised adults), patients must be educated on the proper use of prophylactic antibiotics. Patients traveling to areas of the world with endemic parasitic pathogens (eg, malaria, Babesia) should also be educated about their increased risk of infection with these&#x000a0;intraerythrocytic parasites. Anti-malarial prophylaxis&#x000a0;or other prophylactic antimicrobials may be indicated depending on the region of the world and endemic pathogens present.</p>
      </sec>
      <sec id="article-17905.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The three most common causes of splenectomy include traumatic, neoplastic, and hematologic.<xref ref-type="bibr" rid="article-17905.r21">[21]</xref>&#x000a0;Given the beneficial role the spleen has in immunity, surgical protocols have evolved with efforts to preserve the spleen during emergency surgical operations for trauma patients. Furthermore, alternative, non-surgical interventions for splenic trauma are being increasingly implemented. According to an 8-year study by Rosati et al, there is an increase in non-surgical management of splenic trauma because of the increased use of angiographic embolization.<xref ref-type="bibr" rid="article-17905.r22">[22]</xref>&#x000a0;The spleen has increasingly been recognized as a&#x000a0;vital organ. Preserving the spleen will promote a healthy immune system,&#x000a0;and the infectious and thromboembolic complications often seen in asplenic patients can be avoided. For patients with hematologic etiologies responsible for their functional asplenia and who are prone to have autosplenectomy, their vaccinations should be up to date. Physicians and other healthcare professionals should frequently reassess vaccinations during each follow-up visit.</p>
      </sec>
      <sec id="article-17905.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17905&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17905">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/blood-disorders/asplenia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17905">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17905/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17905">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-17905.s16">
        <title>References</title>
        <ref id="article-17905.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hosey</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Mattacola</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Kriss</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Armsey</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Quarles</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Jagger</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Ultrasound assessment of spleen size in collegiate athletes.</article-title>
            <source>Br J Sports Med</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>40</volume>
            <issue>3</issue>
            <fpage>251</fpage>
            <page-range>251-4; discussion 251-4</page-range>
            <pub-id pub-id-type="pmid">16505083</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17905.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suttie</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <article-title>Histopathology of the spleen.</article-title>
            <source>Toxicol Pathol</source>
            <year>2006</year>
            <volume>34</volume>
            <issue>5</issue>
            <fpage>466</fpage>
            <page-range>466-503</page-range>
            <pub-id pub-id-type="pmid">17067940</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17905.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crary</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Buchanan</surname>
                <given-names>GR</given-names>
              </name>
            </person-group>
            <article-title>Vascular complications after splenectomy for hematologic disorders.</article-title>
            <source>Blood</source>
            <year>2009</year>
            <month>Oct</month>
            <day>01</day>
            <volume>114</volume>
            <issue>14</issue>
            <fpage>2861</fpage>
            <page-range>2861-8</page-range>
            <pub-id pub-id-type="pmid">19636061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17905.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mebius</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Kraal</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Structure and function of the spleen.</article-title>
            <source>Nat Rev Immunol</source>
            <year>2005</year>
            <month>Aug</month>
            <volume>5</volume>
            <issue>8</issue>
            <fpage>606</fpage>
            <page-range>606-16</page-range>
            <pub-id pub-id-type="pmid">16056254</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17905.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Erdem</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Genel</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Erdur</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ozbek</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gulez</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mese</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Asplenia in children with congenital heart disease as a cause of poor outcome.</article-title>
            <source>Cent Eur J Immunol</source>
            <year>2015</year>
            <volume>40</volume>
            <issue>2</issue>
            <fpage>266</fpage>
            <page-range>266-9</page-range>
            <pub-id pub-id-type="pmid">26557043</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17905.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huebner</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Milota</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Asplenia and fever.</article-title>
            <source>Proc (Bayl Univ Med Cent)</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>340</fpage>
            <page-range>340-1</page-range>
            <pub-id pub-id-type="pmid">26130882</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17905.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DeFrances</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Cullen</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Kozak</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>National Hospital Discharge Survey: 2005 annual summary with detailed diagnosis and procedure data.</article-title>
            <source>Vital Health Stat 13</source>
            <year>2007</year>
            <month>Dec</month>
            <issue>165</issue>
            <fpage>1</fpage>
            <page-range>1-209</page-range>
            <pub-id pub-id-type="pmid">18350768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17905.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rose</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Debelak</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pinson</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Harley</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Chapman</surname>
                <given-names>WC</given-names>
              </name>
            </person-group>
            <article-title>The incidence of splenectomy is decreasing: lessons learned from trauma experience.</article-title>
            <source>Am Surg</source>
            <year>2000</year>
            <month>May</month>
            <volume>66</volume>
            <issue>5</issue>
            <fpage>481</fpage>
            <page-range>481-6</page-range>
            <pub-id pub-id-type="pmid">10824750</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17905.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Masiwal</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chenthil</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Priyadarsini</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gnanaprakasam</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Srihari</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Ivemark Syndrome.</article-title>
            <source>J Assoc Physicians India</source>
            <year>2016</year>
            <month>May</month>
            <volume>64</volume>
            <issue>5</issue>
            <fpage>73</fpage>
            <page-range>73-75</page-range>
            <pub-id pub-id-type="pmid">27735157</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17905.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kirkineska</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Perifanis</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Vasiliadis</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Functional hyposplenism.</article-title>
            <source>Hippokratia</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-11</page-range>
            <pub-id pub-id-type="pmid">25125944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17905.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>William</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Corazza</surname>
                <given-names>GR</given-names>
              </name>
            </person-group>
            <article-title>Hyposplenism: a comprehensive review. Part I: basic concepts and causes.</article-title>
            <source>Hematology</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-13</page-range>
            <pub-id pub-id-type="pmid">17364987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17905.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Waghorn</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed.</article-title>
            <source>J Clin Pathol</source>
            <year>2001</year>
            <month>Mar</month>
            <volume>54</volume>
            <issue>3</issue>
            <fpage>214</fpage>
            <page-range>214-8</page-range>
            <pub-id pub-id-type="pmid">11253134</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17905.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rubin</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Schaffner</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Clinical practice. Care of the asplenic patient.</article-title>
            <source>N Engl J Med</source>
            <year>2014</year>
            <month>Jul</month>
            <day>24</day>
            <volume>371</volume>
            <issue>4</issue>
            <fpage>349</fpage>
            <page-range>349-56</page-range>
            <pub-id pub-id-type="pmid">25054718</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17905.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rhodes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Alhazzani</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Antonelli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ferrer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sevransky</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Sprung</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Nunnally</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Rochwerg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rubenfeld</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Angus</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Annane</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Beale</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Bellinghan</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Bernard</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Chiche</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Coopersmith</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>De Backer</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Fujishima</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gerlach</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hidalgo</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Hollenberg</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Karnad</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Kleinpell</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Koh</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lisboa</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Machado</surname>
                <given-names>FR</given-names>
              </name>
              <name>
                <surname>Marini</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Mazuski</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>McIntyre</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>McLean</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moreno</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Myburgh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Navalesi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Nishida</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Osborn</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Perner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Plunkett</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Ranieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schorr</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Seckel</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Seymour</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Shieh</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shukri</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Simpson</surname>
                <given-names>SQ</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Townsend</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Van der Poll</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vincent</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Wiersinga</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Dellinger</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.</article-title>
            <source>Intensive Care Med</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>43</volume>
            <issue>3</issue>
            <fpage>304</fpage>
            <page-range>304-377</page-range>
            <pub-id pub-id-type="pmid">28101605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17905.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Neal</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Niven</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Karam</surname>
                <given-names>GH</given-names>
              </name>
            </person-group>
            <article-title>Critical Illness in Patients With Asplenia.</article-title>
            <source>Chest</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>150</volume>
            <issue>6</issue>
            <fpage>1394</fpage>
            <page-range>1394-1402</page-range>
            <pub-id pub-id-type="pmid">27068019</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17905.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Swirski</surname>
                <given-names>FK</given-names>
              </name>
              <name>
                <surname>Nahrendorf</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Etzrodt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wildgruber</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cortez-Retamozo</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Panizzi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Figueiredo</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Kohler</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Chudnovskiy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Waterman</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Aikawa</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mempel</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Libby</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Weissleder</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pittet</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Identification of splenic reservoir monocytes and their deployment to inflammatory sites.</article-title>
            <source>Science</source>
            <year>2009</year>
            <month>Jul</month>
            <day>31</day>
            <volume>325</volume>
            <issue>5940</issue>
            <fpage>612</fpage>
            <page-range>612-6</page-range>
            <pub-id pub-id-type="pmid">19644120</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17905.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taher</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Isma'eel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mehio</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bignamini</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kattamis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rachmilewitz</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Cappellini</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran.</article-title>
            <source>Thromb Haemost</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>96</volume>
            <issue>4</issue>
            <fpage>488</fpage>
            <page-range>488-91</page-range>
            <pub-id pub-id-type="pmid">17003927</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17905.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schilling</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>Spherocytosis, splenectomy, strokes, and heat attacks.</article-title>
            <source>Lancet</source>
            <year>1997</year>
            <month>Dec</month>
            <day>06</day>
            <volume>350</volume>
            <issue>9092</issue>
            <fpage>1677</fpage>
            <page-range>1677-8</page-range>
            <pub-id pub-id-type="pmid">9400518</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17905.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phrommintikul</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sukonthasarn</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kanjanavanit</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nawarawong</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Splenectomy: a strong risk factor for pulmonary hypertension in patients with thalassaemia.</article-title>
            <source>Heart</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>92</volume>
            <issue>10</issue>
            <fpage>1467</fpage>
            <page-range>1467-72</page-range>
            <pub-id pub-id-type="pmid">16621878</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17905.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hale</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>LaSalvia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kirby</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Kimball</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baden</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Fatal purpura fulminans and Waterhouse-Friderichsen syndrome from fulminant Streptococcus pneumoniae sepsis in an asplenic young adult.</article-title>
            <source>IDCases</source>
            <year>2016</year>
            <volume>6</volume>
            <fpage>1</fpage>
            <page-range>1-4</page-range>
            <pub-id pub-id-type="pmid">27583208</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17905.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Katz</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Pachter</surname>
                <given-names>HL</given-names>
              </name>
            </person-group>
            <article-title>Indications for splenectomy.</article-title>
            <source>Am Surg</source>
            <year>2006</year>
            <month>Jul</month>
            <volume>72</volume>
            <issue>7</issue>
            <fpage>565</fpage>
            <page-range>565-80</page-range>
            <pub-id pub-id-type="pmid">16875077</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17905.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosati</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ata</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Siskin</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Megna</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bonville</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Stain</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Management of splenic trauma: a single institution's 8-year experience.</article-title>
            <source>Am J Surg</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>209</volume>
            <issue>2</issue>
            <fpage>308</fpage>
            <page-range>308-14</page-range>
            <pub-id pub-id-type="pmid">25457232</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
